BCG vaccine greater benefit the earlier it is used. BCG vaccine is in the early stages of being studied in type I diabetes. BCG vaccine Bacillus Calmette–Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis (TB). In countries where tuberculosis or leprosy is common, one dose is recommended in healthy babies as close to the time of birth as possible. In areas where tuberculosis is not common, only children at high risk are typically immunized, while suspected cases of tuberculosis are individually tested for and treated. Adults who do not have tuberculosis and have not been previously immunized but are frequently
Inoculation theory (Banas & Rains, 2010, p. 285). Recent research has studied the presence and function of word-of-mouth communication, or post-inoculation talk (see Compton & Pfau, 2009), following exposure to inoculation messages (e.g., Ivanov et al., 2015). Delay is the next element that is necessary in the inoculation process. There has been much debate on whether there is a certain amount of time necessary between inoculation and further attacks on a persons' attitude that will be most effective in strengthening that person's attitude. McGuire (1961) suggested that delay was necessary strengthening a person's attitude and since then many scholars have found evidence